TAI:3164

GenMont Biotech Incorporation · TAI · Healthcare · TWD · FY for 2025

Figures on this page computed 2026-11-08 12:44 UTC

Last close

n/aTWD

Market data

25.2xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
TWD
- computed
- Computed from the filing for 2025
3.3%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
14.3%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
17.4%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
0.08Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-08
Reported in
TWD
- computed

What it pays out is the furthest below its sector's middle: 0.17 against 0.54 on the market's range.

Five bars, one line

lens 7 of 9

1.03x

1.42x

-2.43x

2.60x

n/a

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Computed2025

Market datan/a

Each against its own average

4 of 5 read

Except where said otherwise: Computed from the filing for 2025

Sales1.03x
Its own average over 10 years, 390.0M.
Profit1.42x
Its own average over 10 years, 40.4M.
Free cash flow-2.43x
Its own average over 10 years, -28.8M.
Debt2.60x
Its own average over 10 years, 42.4M.
Pricen/a
Its own average over 0 years. Market data

Free cash flow is furthest from its own average, at -2.43 times.

Sales is 1.03 times its own 10-year average; Profit is 1.42 times its own 10-year average; Free cash flow is -2.43 times its own 10-year average; Debt is 2.60 times its own 10-year average.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales against its own 10-year average1.03
Source
computed
Statement
income
Fiscal year
2025
Reported in
TWD
Profit against its own 10-year average1.42
Source
computed
Statement
income
Fiscal year
2025
Reported in
TWD
Free cash flow against its own 10-year average-2.43
Source
computed
Statement
income
Fiscal year
2025
Reported in
TWD
Debt against its own 10-year average2.60
Source
computed
Statement
income
Fiscal year
2025
Reported in
TWD
Price against its own 0-year averagen/aMarket data
Not held.
Source
market
Reported in
TWD